(Q72553895)
English
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemi
scientific article published on 01 November 1993
Statements
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583 (English)
C D Bloomfield
H Ozer
S L George
C A Schiffer
K Rao
P N Rao
D H Wurster-Hill
D D Arthur
B Powell
A Gottlieb
B A Peterson
K Rai
J R Testa
M LeBeau
1 November 1993